My takeaways:
-Weekend ceasefire and truce fell flat in
My takeaways:
-Weekend ceasefire and truce fell flat in face; including its author
- GenViro Swift will be huge win for humanity. IMO, requires time in field test (medical professionals) before AtHome use; which will happen mid year, if approved
-GenConfirm could be the saving grace for humanity; offers assurance that your safe, i’m safe
- vision and design should get great acclaim
- diabetic strip portfolio still relevant; need GenChoice approved; last we heard it was in DECN, take a few bucks and make it happen; keep advancing TBG Précis for domestic
- shame DECN doesnt have portfolio in sakes channels; lack some street cred
- company great at design; sales still weak; communications/PR is amateurish (where is the under promise, over deliver); each PR is open invite for bashers and haters; either hire an expert or less is more;
- annual report is way too long; redundant; if needed OK; otherwise time needs to be devoted elsewhere
- product engineering is clear company strength
- good job with 13m;
- tea leaves say company sold, M&A, or license of tech sometime in summer; could be very lucrative
- really like Berman giving credit to M. Musho for design; that’s what leaders do! great job. ps-think
it’s also confirmation of future success!
Ok so let’s get this done DECN. World awaits. Need a win in this fight!
Drop swords! This fight is bigger than vendetta. We all know that. So IMO, it’s a greed play. Hired guns seem to show up everytime company takes step forward. Otherwise it’s low paid contract help spewing BS.
Count your blessings
4
Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...
Continue Reading
Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...
Continue Reading
Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...
Continue Reading
A New Era for EV Batteries in Norway Stepping into Oslo's tech realm, CATL's grand opening is not just another corporate ribbon-cutting spree. It's a big splash in Europe's battery pool, boasting the largest NING SERVICE center outside of Asia. Here we are, folks, at the crossroads where the EV market meets the nitty-gritty of practical service. Norway's Electric...
Continue Reading
A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...
Continue Reading
Saluting the Trailblazers in Rare Disease Space Alright, let's cut to it. In a world flooded with more rare diseases than most of us can count, about 10,000 of them, only a measly 5% have any kind of approved treatment. The National Organization for Rare Disorders (NORD) is out here celebrating the folks who dare to change that bleak outlook. With the 2026 Rare Impact...
Continue Reading
AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...
Continue Reading
An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...
Continue Reading
illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...
Continue Reading
Buckle up, folks. The plastics debate is where regulatory battles and environmental concerns collide, and big changes are on the horizon. Let's talk about Bergeson & Campbell's latest shindig: "Plastics and Policy: Microplastics, EPR, and Other Emerging Trends"—a free-to-join webinar aiming to lift the lid on what's brewing beneath the surface of regulatory waters. The...
Continue Reading
Continue Reading